CA Patent

CA2586807A1 — Topical nepafenac formulations

Assigned to Alcon Inc · Expires 2006-06-08 · 20y expired

What this patent protects

Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.

USPTO Abstract

Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.

Drugs covered by this patent

Patent Metadata

Patent number
CA2586807A1
Jurisdiction
CA
Classification
—
Expires
2006-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Alcon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.